Trial · NCT03449134
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 52-Week Treatment Period | STARTED | Placebo | 244 | |
| 52-Week Treatment Period | STARTED | Gefapixant 15 mg BID | 244 | |
| 52-Week Treatment Period | STARTED | Gefapixant 45 mg BID | 244 | |
| 52-Week Treatment Period | Treated | Placebo | 243 | |
| 52-Week Treatment Period | Treated | Gefapixant 15 mg BID | 244 | |
| 52-Week Treatment Period | Treated | Gefapixant 45 mg BID | 243 | |
| 52-Week Treatment Period | COMPLETED | Placebo | 199 | |
| 52-Week Treatment Period | COMPLETED | Gefapixant 15 mg BID | 200 | |
| 52-Week Treatment Period | COMPLETED | Gefapixant 45 mg BID | 184 | |
| 52-Week Treatment Period | NOT COMPLETED | Placebo | 45 | |
| 52-Week Treatment Period | NOT COMPLETED | Gefapixant 15 mg BID | 44 | |
| 52-Week Treatment Period | NOT COMPLETED | Gefapixant 45 mg BID | 60 | |
| 12-Week Off-Treatment Durability Period | STARTED | Placebo | 10 | |
| 12-Week Off-Treatment Durability Period | STARTED | Gefapixant 15 mg BID | 18 | |
| 12-Week Off-Treatment Durability Period | STARTED | Gefapixant 45 mg BID | 13 | |
| 12-Week Off-Treatment Durability Period | COMPLETED | Placebo | 10 | |
| 12-Week Off-Treatment Durability Period | COMPLETED | Gefapixant 15 mg BID | 18 | |
| 12-Week Off-Treatment Durability Period | COMPLETED | Gefapixant 45 mg BID | 13 | |
| 12-Week Off-Treatment Durability Period | NOT COMPLETED | Placebo | 0 | |
| 12-Week Off-Treatment Durability Period | NOT COMPLETED | Gefapixant 15 mg BID | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03449134/flow